• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Parasol Therapeutics

edit

Parasol Therapeutics does research on influenza diagnostics and treatment. They were in seed/stealth stage as of June 2009.

Recent Milestones

edit

• 
  Parasol Therapeutics received $3.2M in Venture Round funding. (11/30/09)
  Posted 12/8/09 at 5:13pm via sec.gov
• 
  Parasol Therapeutics received $3.25M in Series A funding. (5/10/09)
  Posted 6/23/09 at 12:36pm via onbiovc.com
• 
  Parasol Therapeutics added Kevin Bitterman as Co-founder.
  Posted 4/16/13 at 3:50am
• 
  Parasol Therapeutics added Kevin Bitterman as Director .
  Posted 4/16/13 at 3:54am
• 
  Parasol Therapeutics added Ed Kania as Director.
  Posted 4/16/13 at 8:52am

Videos

Screenshots

edit

Sources

1. Parasol Therapeutics, Inc.: Series A $3.25M (onbiovc.com) [edit]
2. SEC D (sec.gov) [edit]